Osamu Kanazawa
- Psychiatry and Mental health top 2%
- Pediatrics, Perinatology and Child Health top 5%
- Cognitive Neuroscience top 10%
- Cellular and Molecular Neuroscience top 10%
- Neurology
- Co-authors
- Shigeki KameyamaMutsuo SasagawaJun TohyamaMakoto OishiWarren T. BlumeJohn P. GirvinHiroshi MasudaNoriyuki Akasaka
- Topics
- Epilepsy research and treatment (27 papers)Pharmacological Effects and Toxicity Studies (8 papers)Neuroscience and Neuropharmacology Research (7 papers)
- Cited by
- Psychiatry and Mental healthPediatrics, Perinatology and Child HealthCognitive Neuroscience
- Partner nations
- JapanUnited StatesCanada
In The Last Decade
Osamu Kanazawa
39 papers receiving 593 citations
Peers
Comparison fields: 5 of 54
- Psychiatry and Mental health 473
- Pediatrics, Perinatology and Child Health 220
- Cognitive Neuroscience 215
- Cellular and Molecular Neuroscience 177
- Neurology 68
Countries citing papers authored by Osamu Kanazawa
This map shows the geographic impact of Osamu Kanazawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Osamu Kanazawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Osamu Kanazawa more than expected).
Fields of papers citing papers by Osamu Kanazawa
This network shows the impact of papers produced by Osamu Kanazawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Osamu Kanazawa. The network helps show where Osamu Kanazawa may publish in the future.
Co-authorship network of co-authors of Osamu Kanazawa
This figure shows the co-authorship network connecting the top 25 collaborators of Osamu Kanazawa. A scholar is included among the top collaborators of Osamu Kanazawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Osamu Kanazawa. Osamu Kanazawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 14 | |
| 2 | 12 | |
| 3 | 38 | |
| 4 | 100 | |
| 5 | 31 | |
| 6 | 19 | |
| 7 | Can early zonisamide medication improve the prognosis in the core and peripheral types of severe myoclonic epilepsy in infants | 5 |
| 8 | 2 | |
| 9 | 11 | |
| 10 | 67 | |
| 11 | [Clinical characteristics and outcome of 508 patients with hyperventilation syndrome]. | 7 |
| 12 | 16 | |
| 13 | 2 | |
| 14 | 19 | |
| 15 | 11 | |
| 16 | 2 | |
| 17 | 10 | |
| 18 | 21 | |
| 19 | 2 | |
| 20 | 2 |
About Osamu Kanazawa
Osamu Kanazawa is a scholar working on Psychiatry and Mental health, Pediatrics, Perinatology and Child Health and Cellular and Molecular Neuroscience, having authored 39 papers that have together received 610 indexed citations. Recurring topics across this work include Epilepsy research and treatment (27 papers), Pharmacological Effects and Toxicity Studies (8 papers) and Neuroscience and Neuropharmacology Research (7 papers). The work is most often cited by research in Psychiatry and Mental health (473 citations), Pediatrics, Perinatology and Child Health (220 citations) and Cognitive Neuroscience (215 citations). Osamu Kanazawa has collaborated with scholars based in Japan, United States and Canada. Frequent co-authors include Shigeki Kameyama, Mutsuo Sasagawa, Jun Tohyama, Makoto Oishi, Warren T. Blume, John P. Girvin, Hiroshi Masuda, Noriyuki Akasaka, Hiroshi Otsubo and Masafumi Fukuda. Their work appears in journals such as Epilepsia, Epilepsy & Behavior and Pediatric Neurology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.